Current Research in Biotechnology最新文献

{"title":"Selection of aptamer for creatine Kinase-MM as a marker for muscular dystrophy and myocardial infarction","authors":"Albert M Liao ,&nbsp;Shailaja Agrawal ,&nbsp;James Cory Benson ,&nbsp;G. Thomas Caltagirone","doi":"10.1016/j.crbiot.2024.100229","DOIUrl":"https://doi.org/10.1016/j.crbiot.2024.100229","url":null,"abstract":"<div><p>Creatine kinase-MM (CK-MM) is a relatively muscle-specific enzyme with a plasma half-life of approximately 2 h. Total creatine kinase elevation is evident in several conditions associated with acute muscle injury, severe muscular exertion, and myocardial infarction. The presence of a large amount of the CK-MM enzyme in blood serum is a biomarker of muscular injuries and cardiac assault. In this study, we developed a structure-switching aptamer that can be immobilized on a sensor to detect CK-MM. CK-BB was used as a counter-target to ensure the specific targeting of CK-MM. Melting-Off SELEX was employed to develop aptamers exhibiting significant structural changes on binding. The selected aptamer shows a high affinity towards CK-MM with a K_d value of 14.7 nM.</p></div>","PeriodicalId":52676,"journal":{"name":"Current Research in Biotechnology","volume":"7 ","pages":"Article 100229"},"PeriodicalIF":5.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590262824000558/pdfft?md5=f3b0eaa258043b204aeb1269ea2335fb&pid=1-s2.0-S2590262824000558-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141240229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Carotenoid production by Haloferax mediterranei using starch residues from the candy industry as a carbon source","authors":"Micaela Giani ,&nbsp;Carmen Pire ,&nbsp;Rosa María Martínez-Espinosa","doi":"10.1016/j.crbiot.2024.100265","DOIUrl":"10.1016/j.crbiot.2024.100265","url":null,"abstract":"<div><div>Carotenoids are pigments attracting the attention of several industries due to their antioxidant, biological and coloring properties. Low-cost substrates, such as agro-industrial wastes, are being investigated as a viable option to reduce microbial production costs in processes in which microorganisms such as haloarchaea are used as cell factories to produce marketed compounds like carotenoids. They can grow on various agro-industrial wastes and produce the C₅₀ carotenoid bacterioruberin (BR), which is an extraordinary antioxidant compound with anticancer properties. In this study, the haloarchaeon <em>Haloferax mediterranei</em> is grown in the presence of starch residues from the<!--> <!-->candy industry to induce the production of carotenoids. Cells grew successfully with this industrial waste (max. O.D. 600 nm = 27.75 ± 0.09). Biomass production increased in the presence of higher quantities of starch up to 17.3 ± 0.2 mg/ml of cell culture. The maximum BR concentration was 97.39 ± 1.86 µg/ml. The total amount of BRs synthesized increased when cells grew with increasing concentrations of the industrial starch. The relative percentages of all-<em>trans</em>-BR, 5<em>-cis</em>-BR and a double isomeric BR rose, whereas 9-<em>cis</em>-BR and 13-<em>cis</em>-BR levels decreased.</div><div>Herein, haloarchaeal growth and carotenoid production can be enhanced using industrial waste products as the starch residues selected for this experiment which were provided by a candy company.</div></div>","PeriodicalId":52676,"journal":{"name":"Current Research in Biotechnology","volume":"8 ","pages":"Article 100265"},"PeriodicalIF":3.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142661145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Agrobacterium tumefaciens-mediated transformation for the genetic modification of the biotechnologically relevant fungus Aspergillus vadensis through synthetic biology","authors":"Carolina Ropero-Pérez,&nbsp;Paloma Manzanares,&nbsp;Jose F. Marcos,&nbsp;Sandra Garrigues","doi":"10.1016/j.crbiot.2024.100178","DOIUrl":"https://doi.org/10.1016/j.crbiot.2024.100178","url":null,"abstract":"<div><p>In the last years, many research efforts have been applied for the development of filamentous fungi as hosts for heterologous protein production. <em>Aspergillus vadensis</em> CBS 113365, a close relative of the industrial workhorse <em>Aspergillus niger</em>, has been suggested as a more suitable cell factory as it does not acidify the culture medium and produces very low levels of secreted proteases. Therefore, efficient methods and tools that allow the genetic manipulation and exploitation of this biotechnologically relevant fungus are needed. To date, only protoplast-mediated transformation and classical cloning strategies have been implemented for <em>A. vadensis</em> genetic modification, which decreases the exploitation capacity of this fungus at the industrial level. In this study, we have adapted and implemented an <em>Agrobacterium tumefaciens-</em>mediated transformation protocol for <em>A. vadensis</em> for the first time, and applied the FungalBraid system to genetically modify this species by means of synthetic biology. As proof of concept, we have successfully complemented and fluorescently labelled a uridine auxotrophic <em>A. vadensis pyrA^-</em> strain and generated <em>A. vadensis</em> mutants carrying the <em>Penicillium expansum</em>-based expression cassette for the heterologous production of the antifungal protein PeAfpA from <em>P. expansum</em>. Even though we have yet to find the conditions that trigger PeAfpA production in this species, the implementation of the ATMT method reported here, along with the application of the FungalBraid system, will greatly aid in this task and will facilitate the exploitation of <em>A. vadensis</em> as a fungal workhorse for protein production for multiple biotechnological applications.</p></div>","PeriodicalId":52676,"journal":{"name":"Current Research in Biotechnology","volume":"7 ","pages":"Article 100178"},"PeriodicalIF":5.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590262824000042/pdfft?md5=0a49fe4461640e9825957bfc2ee33df5&pid=1-s2.0-S2590262824000042-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139487663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Light emitting diode (LED) lights for the improvement of plant performance and production: A comprehensive review","authors":"Saikat Sena ,&nbsp;Soni Kumari ,&nbsp;Vijay Kumar ,&nbsp;Azamal Husen","doi":"10.1016/j.crbiot.2024.100184","DOIUrl":"https://doi.org/10.1016/j.crbiot.2024.100184","url":null,"abstract":"<div><p>Light quality (spectral arrangement) and quantity (photoperiod and intensity) influence plant growth and metabolism and also interact with several factors including environmental parameters in defining the plant behavior. The Light Emitting Diode (LED) lights are extensively utilized in the cultivation of several plant species, especially horticultural plants due to their lower power consumption and higher luminous efficiency compared to the conventional fluorescent lights. The aim of this review paper is to examine the potential of LED technology as it relates to plant lighting in greenhouses and other horticultural environments. It also desires to give an in-depth study of the advantages of LED lighting on plant development, yield, the production of secondary metabolites, and defense mechanisms. Horticultural lighting might undergo a revolution because LEDs are used in solid-state lighting, which would be a tremendous advancement after decades of research. LEDs may be used in a variety of horticulture lighting applications, such as tissue culture lighting, controlled environment research lighting, supplementary lighting, and photoperiod lighting for greenhouses. The primary impacts of light colors on plant performance are shown by the spectrum effects of LEDs as an independent source of light, together with the diverse sensitivity of many plant species and alternatives. LED light influences performance of enzyme, gene expression, cell wall formation, plant defense and postharvest quality. The spectrum reactions are mediated by the ambient lighting in a greenhouse, which also indicates a strong relationship between the additional supplementary lighting and changing environmental factors. LEDs are growing further to become cost-effective for even large-scale horticulture lighting applications as light output increases and device expenditures decrease.</p></div>","PeriodicalId":52676,"journal":{"name":"Current Research in Biotechnology","volume":"7 ","pages":"Article 100184"},"PeriodicalIF":5.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590262824000108/pdfft?md5=45bc5c6f3ec8a6e97e7afac6a34cf132&pid=1-s2.0-S2590262824000108-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139737873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Isopentyl caffeate as a promising drug for the treatment of leishmaniasis: An in silico and in vivo study","authors":"Wanessa S. Mota ,&nbsp;Simone S.C. Oliveira ,&nbsp;Matheus M. Pereira ,&nbsp;Damião P. Souza ,&nbsp;Mayara Castro ,&nbsp;Pollyanna S. Gomes ,&nbsp;Herbert L.M. Guedes ,&nbsp;Vinícius F. Souza ,&nbsp;André L.S. Santos ,&nbsp;Ricardo L.C. Albuquerque-Junior ,&nbsp;Juliana C. Cardoso ,&nbsp;Cristina Blanco-Llamero ,&nbsp;Sona Jain ,&nbsp;Eliana B. Souto ,&nbsp;Patrícia Severino","doi":"10.1016/j.crbiot.2024.100209","DOIUrl":"https://doi.org/10.1016/j.crbiot.2024.100209","url":null,"abstract":"<div><p>Leishmaniasis is recognised as the second largest parasitic disease worldwide and yet a neglected disease. The current pharmacological treatments are associated with significant challenges, including high toxicity, high cost and parasitic resistance. Considering the potential of isopentyl caffeate (ICaf) as an anti-leishmanial agent, the present work evaluated the <em>in vivo</em> toxicity of ICaf and the absorption, distribution, metabolism, and excretion (ADME) properties <em>in silico</em>, aiming at the treatment of <em>Leishmania amazonensis</em>. For the <em>in vivo</em> toxicity testing, Swiss mice (<em>Mus musculus</em>) were treated with a single dose of ICaf. During the 14-day evaluation period, the animals underwent assessments including hippocratic screening, weight measurement, as well as histological and hematological evaluations. Analysis of ADME properties of ICaf was conducted to evaluate its pharmacokinetic characteristics and bioavailability. Characteristics, such as molar refractivity through Lipinski's Rule of Five, were identified. The <em>in silico</em> results showed that ICaf is considered to have good oral bioavailability and has potential to be considered as a new drug. From the <em>in vivo</em> toxicity testing, none of the evaluated parameters revealed toxicity of ICaf to the animals when treated intraperitoneally. The <em>in vivo</em> treatment reduced the lesion and the parasite load at the tested doses, corroborating the assumption that ICaf may be a potential pharmacological alternative against <em>L. amazonensis</em>.</p></div>","PeriodicalId":52676,"journal":{"name":"Current Research in Biotechnology","volume":"7 ","pages":"Article 100209"},"PeriodicalIF":5.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590262824000352/pdfft?md5=34b6b52f6490ccae56027b2ac7ff33f1&pid=1-s2.0-S2590262824000352-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140536111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A BAR homology domain containing protein, EhABP is the novel interactor of EhAK7, an aurora kinase homolog in E. histolytica","authors":"Raktim Ghosh ,&nbsp;Pinaki Biswas ,&nbsp;Abhinaba Chakraborty ,&nbsp;Suchetana Pal ,&nbsp;Moubonny Das ,&nbsp;Somasri Dam","doi":"10.1016/j.crbiot.2024.100216","DOIUrl":"https://doi.org/10.1016/j.crbiot.2024.100216","url":null,"abstract":"<div><p>Biomolecular interactions among proteins are fundamental for all cellular functions. The chromosome segregation proteins are the key regulators of inherent functions in the living cells. Aurora kinases have drawn much interest as possible drug targets in higher eukaryotes. The human pathogen, <em>E. histolytica</em> is the causative agent of amoebiasis, and a major health concern in developing countries. However, there is no vaccine against it and the popular drugs- metronidazole, tinidazole etc. show significant side effects in humans. To identify new controlling agents, we must have a thorough knowledge about the cell cycle regulatory proteins of <em>E. histolytica</em>, as many unusual cell cycle events can be found in this parasite, that do not happen in human cells. This study describes the first comprehensive analysis of the interaction between an aurora kinase protein and a BAR homology domain containing protein. Fes/CIP4 and EFC/F-BAR homology domain (FCH) containing protein, EhABP has been identified as a novel interactor of EhAK7, an aurora kinase homolog from <em>E. histolytica</em> by yeast two-hybrid screening against the cDNA library of <em>E. histolytica</em> and their interaction has been proved by <em>in vitro</em> binding assay. Both the N and C-terminus of EhAK7 are responsible for this interaction. We found the reduced expression of EhAK7 and EhABP genes, defects in actin filament organization and irregular-shaped nucleus in the trophozoites treated with an aurora kinase inhibitor VX-680. This indicates that EhAK7 play an important role in the cytokinesis of <em>E. histolytica</em> through the interaction with a BAR homology domain containing protein, EhABP.</p></div>","PeriodicalId":52676,"journal":{"name":"Current Research in Biotechnology","volume":"7 ","pages":"Article 100216"},"PeriodicalIF":5.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S259026282400042X/pdfft?md5=a34104d85ebf1154fae15c78b59a9016&pid=1-s2.0-S259026282400042X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140644837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"AutoTarget: Disease-Associated druggable target identification via node representation learning in PPI networks","authors":"Hyunseung Kong ,&nbsp;Inyoung Kim ,&nbsp;Byoung-Tak Zhang","doi":"10.1016/j.crbiot.2024.100260","DOIUrl":"10.1016/j.crbiot.2024.100260","url":null,"abstract":"<div><div>Drug target discovery, a pivotal early stage in drug development, is resource-intensive and crucial for ensuring drug efficacy. This study presents AutoTarget, a novel computational pipeline designed to identify disease-associated druggable targets by applying node representation learning to protein–protein interaction (PPI) networks. AutoTarget uses node2vec + for node classification, incorporating neighborhood context and structural equivalence in PPI networks derived from the STRING database. Data from the Therapeutic Target Database (TTD) and DisGeNET were integrated to identify known drug targets and gene-disease associations, respectively. Each protein is embedded into a 128-dimensional vector space, capturing local network structures and enabling the identification of structurally equivalent proteins. A Naïve Bayes classifier, trained on these embeddings, achieved a recall of 0.90 and an F1 score of 0.79 in predicting potential drug targets. AutoTarget identified 3,979 novel potential druggable target proteins out of 19,333 proteins in the PPI network, which were mapped to 23,363 diseases using DisGeNET. This creates a comprehensive resource for disease-specific drug target exploration. Case studies on triple-negative breast cancer and obesity demonstrated AutoTarget’s capability to identify both established and emerging targets, such as CD44, MAPK3, and GIP. Visualization of embedding vectors using t-SNE revealed clear separations between functional protein families, including nuclear proteins, growth factor receptors, and the G proteins within the kinase proteins. This supports the method’s ability to capture biologically relevant information. However, limitations were noted, including the inability to distinguish between different types of disease-associated proteins based solely on network features. Overall, this study advances the application of machine learning and network theory for identifying druggable targets across a wide range of diseases. AutoTarget provides researchers with a valuable tool for expediting the discovery of novel druggable targets, potentially streamlining the drug discovery process. The AutoTarget code and database are publicly available to facilitate further research.</div></div>","PeriodicalId":52676,"journal":{"name":"Current Research in Biotechnology","volume":"8 ","pages":"Article 100260"},"PeriodicalIF":3.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Chatting with artificial intelligence to combat antibiotic resistance: Opportunities and challenges","authors":"Mohammad Abavisani ,&nbsp;Alireza Khoshrou ,&nbsp;Sobhan Karbas Foroushan ,&nbsp;Amirhossein Sahebkar","doi":"10.1016/j.crbiot.2024.100197","DOIUrl":"https://doi.org/10.1016/j.crbiot.2024.100197","url":null,"abstract":"<div><p>Antibiotic resistance (ABR) is a dire global health crisis, undermining the efficacy of antibiotics and ranking among the top ten public health threats according to the World Health Organization. Despite multifaceted efforts to tackle ABR, complex challenges persist across scientific, economic, behavioral, ethical, and legal dimensions. Artificial intelligence (AI), which encompasses machine capabilities for human-like tasks, offers a wide range of applications in healthcare. Chatbots, a subtype of AI, emerge as a powerful avenue for natural language interaction with users. In healthcare, chatbots have demonstrated value in symptom assessment, mental health support, medication adherence, and patient engagement. In this context, our article will comprehensively examine the opportunities and challenges presented by chatbots in bacterial disease management and ABR mitigation. We will delve into not only the technical considerations but also the ethical, legal, and social complexities accompanying their integration into healthcare. The current consideration will be valuable for healthcare professionals, policymakers, and researchers as they navigate the dynamic intersection of chatbots and the pressing issue of antibiotic resistance.</p></div>","PeriodicalId":52676,"journal":{"name":"Current Research in Biotechnology","volume":"7 ","pages":"Article 100197"},"PeriodicalIF":5.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590262824000236/pdfft?md5=510a3f6da3dcf5ee6fd73f2a753f14e1&pid=1-s2.0-S2590262824000236-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140133929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Balancing long-term enriched partial denitrifying bacteria and anammox bacteria for carbon-neutral mainstream nitrogen removal","authors":"Soyeon Jeong ,&nbsp;Seongjae Park ,&nbsp;Jeongmi Kim ,&nbsp;Yeonju Kim ,&nbsp;Hojun Kim ,&nbsp;Seongwon Yoon ,&nbsp;Jaecheul Yu ,&nbsp;Taeho Lee","doi":"10.1016/j.crbiot.2024.100224","DOIUrl":"https://doi.org/10.1016/j.crbiot.2024.100224","url":null,"abstract":"<div><p>Anaerobic ammonium oxidation (anammox)-based process has become a method for achieving carbon-neutral wastewater treatment. However, in mainstream wastewater with a low-strength ammonium, obtaining partial nitritation (PN) for the anammox process can be challenging and often result in NO₃^– accumulation. The recently proposed partial denitrification (PD), which reduces NO₃^– back to NO₂^–, can provide NO₂^– for anammox. For a successful PD-anammox (PD/A), it is crucial to efficiently cultivate PD bacteria (PDNB) and maintain a balance between the activities of PDNB and anammox bacteria (AnAOB). In this study, an efficient PDNB enrichment was cultivated for a long period of 400 days in a sequential batch reactor (SBR) by feeding it with acetate (300 mg COD/L) and nitrate (100 mg NO₃^–-N/L) at an exchange ratio of 50 %. The nitrite accumulation efficiency (NAE) gradually increased to &gt;90 %, with <em>Thauera phenylacetica</em> identified as the key species for achieving high NAE. When PDNB was applied with AnAOB to remove 50 mg NH₄⁺-N/L and 50 mg NO₃^–-N/L, different total nitrogen (TN) removal efficiencies were observed depending on the mixing ratio of PDNB and AnAOB (1:5–1:20). The most rapid and complete TN removal was achieved at the mixing ratio of 1:15. At lower mixing ratios of 1:5 and 1:10, PDNB activity exceeded that of AnAOB, resulting in incomplete TN removal. Conversely, at a higher inoculation ratio of 1:20, AnAOB activity surpassed of PDNB, leading to delayed T-N removal. These results indicate that maintaining a balance between NO₂^– accumulation by PDNB and NO₂^– consumption by AnAOB is essential for successful PD/A process operation. The findings of this study can be utilized as fundamental data for the operational strategy of an anammox-based process to achieve a carbon-neutral wastewater treatment.</p></div>","PeriodicalId":52676,"journal":{"name":"Current Research in Biotechnology","volume":"7 ","pages":"Article 100224"},"PeriodicalIF":5.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590262824000509/pdfft?md5=3a0fd187003802bf20a8da47b4a20fe3&pid=1-s2.0-S2590262824000509-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140824126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fucoxanthin: From chemical properties and sources to novel anticancer mechanistic insights and synergistic therapeutic opportunities","authors":"Wojciech Koch ,&nbsp;Wirginia Kukula-Koch ,&nbsp;Anna Wawruszak ,&nbsp;Estera Okoń ,&nbsp;Katarzyna Stępnik ,&nbsp;Katarzyna Gaweł-Bęben ,&nbsp;William N. Setzer ,&nbsp;Irene Dini ,&nbsp;Javad Sharifi-Rad ,&nbsp;Daniela Calina","doi":"10.1016/j.crbiot.2024.100203","DOIUrl":"https://doi.org/10.1016/j.crbiot.2024.100203","url":null,"abstract":"<div><p>Fucoxanthin (FX) is a carotenoid of marine origin primarily distributed in brown seaweeds and has garnered interest for its antioxidative, anti-inflammatory, and anticancer properties. Despite its potential, a comprehensive understanding of its anticancer effects and mechanisms of action remains elusive.</p><p>The aim of this review is to present novel insights into the anticancer effects of FX, shedding light on previously unexplored molecular mechanisms and its synergistic potential with established chemotherapeutic agents.</p><p>A comprehensive search was conducted employing databases like PubMed/MedLine, Scopus, and Web of Science to aggregate relevant pharmacological experimental studies. The results of the studies showed that FX exhibits anticancer activity against various cancer types, including breast, colorectal, and lung cancer, through multiple pathways: cell cycle arrest, apoptosis induction, and inhibition of angiogenesis. Additionally, FX potentiates the effects of existing chemotherapeutic agents, making it a potential candidate for combination therapies. The evidence suggests that FX possesses considerable anticancer properties, acting through diverse molecular mechanisms; the heterogeneity of study designs and the limited number of clinical trials make it hard to conclude. Further in-depth studies, particularly randomized controlled trials, are essential for validating FX's efficacy and for paving the way for its integration into standard cancer treatment regimens; additional research is needed to explore its pharmacokinetics, safety profile, and potential synergistic effects with existing chemotherapeutics.</p></div>","PeriodicalId":52676,"journal":{"name":"Current Research in Biotechnology","volume":"7 ","pages":"Article 100203"},"PeriodicalIF":5.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590262824000297/pdfft?md5=e6441fb7a74e44a4bcbbb15179e39e74&pid=1-s2.0-S2590262824000297-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140308691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}